Denali Therapeutics
Price & Volume
Stats
See more52W Range | $10.57-$24.34 |
Market Cap | $2.8B |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$420.6M |
Diluted EPS | -$2.92 |
News
See moreYahoo Finance • 18 days ago
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)
Yahoo Finance • 19 days ago
3 Biotech Stocks With Major 2026 Catalysts
Yahoo Finance • last month
Denali Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Yahoo Finance • last month
Denali Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
About
CEO | Dr. Ryan J. Watts Ph.D. |
CFO | Dr. Alexander O. Schuth M.D., Ph.D. |
Address | 161 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 517 |
